Methyl 2-[(E)-{2-hydroxy-3-[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)carbamoyl]-1-naphthyl}diazenyl]benzoate(CAS: 6985-92-8)

This compound is subject to GHS classification for hazardous chemicals. It also falls under REACH regulations for identifying and managing chemical risks. The FDA and EPA may have additional requirements for its use and disposal in the United States. Compliance with these regulations is essential to ensure safety and legal standards are met.

Alternatives in synthesis might include using different starting materials or reagents, such as other naphthyl derivatives or benzimidazole analogs. These alternatives can offer similar functional groups but with different chemical properties, potentially providing more flexible synthetic routes.

Research trends for this compound indicate growing interest in its use as a potential drug candidate due to its unique chemical structure. Market trends suggest increasing demand in pharmaceutical research, particularly in areas of cancer and inflammatory diseases. Continued exploration of its biological activity and clinical potential is expected to drive further market growth.

Waste containing this compound should be collected in appropriate containers and handled according to local waste management regulations. For incineration, ensure that the waste is properly pre-treated to minimize environmental impact. Professional waste disposal services are recommended to ensure compliance with environmental protection standards and safe disposal.